Tolero Pharmaceuticals
Lehi, US · Founded 2011
Founders & leadership
Tolero Pharmaceuticals was founded in 2011 by David Bearss, Ph.D. and Dallin Anderson.
DB
David Bearss, Ph.D.Co-founder
DA
Dallin AndersonCo-founder
Reported raises · per SEC filings
Form D private placements$22.5M disclosed across 1 round · 2014
▶$22.5MraisedDec 2014 · 48 investors · PharmaceuticalsRule 506(b)
▶$22.5MraisedDec 2014 · 48 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David Bearss, Ph.D.Executive Officer, Director, Promoter
- Dallin AndersonExecutive Officer, Director, Promoter
- Offering amount
- $35.5M
- Amount sold
- $22.5M
- Finders' fees
- $1.5M
- Placement agents
- T.R. Winston & Company, LLC
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Tolero Pharmaceuticals?
- Tolero Pharmaceuticals was founded by David Bearss, Ph.D., Dallin Anderson in 2011.
- How much funding has Tolero Pharmaceuticals raised?
- Tolero Pharmaceuticals has disclosed $22.5M raised across 1 round.
- Where is Tolero Pharmaceuticals headquartered?
- Tolero Pharmaceuticals is headquartered in Lehi, US.